Press

  • MM+M Game Changers 2023: Insagic Profile

    MM+M Game Changers 2023: Insagic Profile

    Verilogue is now part of Insagic, a Publicis Health company, is a groundbreaking insights and advisory business that combines data, design, and dialogues to deliver activatable insights and transformational intelligence that our clients need to succeed and grow in today’s platform world. Read the MM+M Game Changers 2023 profile here.

  • Zach Hebert Named to Greenbook’s Future List 2023

    Zach Hebert Named to Greenbook’s Future List 2023

    Insagic, a next-generation insights and advisory business that combines data, design, and dialogues, announced today that its Manager, Linguistic Insights & Analytics Zach Hebert has been named an honoree to the GreenBook Future List 2023.

  • Verilogue’s Mark Andrews featured in PharmaVoice Article on Voice Assistants

    Verilogue’s Mark Andrews featured in PharmaVoice Article on Voice Assistants

    December 1, 2018 – “Voice assistants are going to continue to gain tremendous ground and greatly impact the industry over the coming years for many reasons, but perhaps the most important one is: they are so easy for consumers to use. We all know how to use our voice to ask a question.” To read…

  • A Patient Complained About The Cost Of Her Medical Care. Here’s How Her Doctor Responded.

    A Patient Complained About The Cost Of Her Medical Care. Here’s How Her Doctor Responded.

    [vc_row][vc_column][vc_column_text]November 14, 2018 – “Patients pay a price for the inexplicably high cost of U.S. healthcare, not just in the size of their monthly insurance premiums or the expense of their copays and deductibles. They also experience the harm of losing trust in our nation’s healthcare system.” To view the entire article by Peter Ubel,…

  • Should You Get That Scan? Your Doctor Might Not Be Great At Helping You Decide

    Should You Get That Scan? Your Doctor Might Not Be Great At Helping You Decide

    August 18, 2018 – “Your doctor probably nags you to schedule cancer screening tests like mammograms and colonoscopies. These tests, after all, can be life-saving, and most doctors want to make sure you get them done. But when it comes to explaining the ways that certain screenings can cause you harm, your doctor may not…

  • Doctor-patient discussions neglect potential harms of lung cancer screening, study finds

    Doctor-patient discussions neglect potential harms of lung cancer screening, study finds

    August 13, 2018 – “Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren’t happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger…

  • What Confusion About Health Insurance Looks Like In The Doctor’s Office

    What Confusion About Health Insurance Looks Like In The Doctor’s Office

    September 29, 2017 – “As the country considers ways to once again reform its healthcare system, we have to remember that competition among insurance companies can become so confusing as to bewilder patients and physicians, thereby thwarting their ability to get affordable treatments for people with serious illnesses like rheumatoid arthritis. When it comes to…

  • VERILOGUE STUDY: HOW ONLINE PATIENT COMMUNITIES ARE INFLUENCING THE DOCTOR-PATIENT DIALOGUE

    VERILOGUE STUDY: HOW ONLINE PATIENT COMMUNITIES ARE INFLUENCING THE DOCTOR-PATIENT DIALOGUE

    HORSHAM, Pa. – November 10, 2010 – The doctor-patient relationship has long been an asymmetric one in which the physician’s clinical agenda trumps the patient’s need to voice and explore his/her health concerns. To bridge this gap in competing priorities, many patients turn to online third-party resources, such as Internet-based health support groups and health…

  • VERILOGUE ANNOUNCES NEW GLOBAL MARKET RESEARCH OFFERING

    HORSHAM, Pa. November 5, 2010 – Innovative health care market research firm Verilogue continues its trend of rapid growth with the announcement that it now provides pharmaceutical marketers with the same unique insight into the physician-patient conversation on a global scale. As it moves into the European market, Verilogue remains true to its core business…

  • VERILOGUE DEBUTS ON DELOITTE’S 2010 GREATER PHILADELPHIA FAST 50

    HORSHAM, Pa. October 25, 2010 – Global pharmaceutical market research firm, Verilogue, receives Rising Star recognition in Deloitte’s Fast 50 Program for Greater Philadelphia in 2010. The Fast 50 ranking recognizes the fastest growing technology, media, telecommunications and life sciences companies in the area based on percentage revenue growth over a five year period. A…